Grace Therapeutics
GRCE · NASDAQ
$1.98+$0.10 (+5.32%)TodayMarket closed ·
Prev close $1.88
Who owns GRCE
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 36.6% of GRCE’s shares.
- Shore Pharma LLC7.3%
- Adar1 Capital Management LLC5.9%
- SS Pharma LLC5.7%
- Rajitha Grace 2018 Irrevocable Trust4.8%
- Next 6 largest institutions12.9%
- All other shareholders63.4%
| Holder | Shares | % of shares |
|---|---|---|
| Shore Pharma LLC | 1.19M | 7.30% |
| Adar1 Capital Management LLC | 959.57K | 5.90% |
| SS Pharma LLC | 931.74K | 5.73% |
| Rajitha Grace 2018 Irrevocable Trust | 781.59K | 4.80% |
| BofA Global Research (US) | 494.70K | 3.04% |
| Kottayil (George) | 494.70K | 3.04% |
| AIGH Capital Management, LLC. | 478.25K | 2.94% |
| Kavuru (Vimal) | 426.32K | 2.62% |
| Worth Venture Partners, LLC | 162.83K | 1.00% |
| Neugeboren (Edward) | 37.90K | 0.23% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 225.00K | 1.38% |
| Fidelity NASDAQ Composite Index Fund | 3.06K | 0.02% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $639.56K (18 trades) of GRCE on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Opaleye Management Inc. | Buy | 36.35K | $68.76K |
| Opaleye Management Inc. | Buy | 23.48K | $45.69K |
| Opaleye Management Inc. | Buy | 11.23K | $21.73K |
| Opaleye Management Inc. | Buy | 7.21K | $14.57K |
| Opaleye Management Inc. | Buy | 5.34K | $10.92K |
| Opaleye Management Inc. | Buy | 2.08K | $4.19K |
| Opaleye Management Inc. | Buy | 1.69K | $3.49K |
| Opaleye Management Inc. | Buy | 20.00K | $41.37K |
| Opaleye Management Inc. | Buy | 38.80K | $78.96K |
| Opaleye Management Inc. | Buy | 7.85K | $16.40K |
Short interest
Settled Sep 30, 2026
- Shares short
- 1.72M
- Days to cover
- 19.03
- % of shares outstanding
- 10.58%
- Average daily volume
- 90.44K
- Change since last report
- −2.5%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.